
Bivastat 250mg Injection
Marketer
Cipla Ltd
Salt Composition
Bivalirudin (250mg)
Overview Bivastat 250mg Injection
Clotix 250mg Injection, a blood thinner (anticoagulant), prevents and treats blood clots, lowering the risk of stroke and heart attack. It combats clot formation in leg, lung, brain, and heart veins. Frequently administered intravenously to atrial fibrillation patients to prevent clots, it's also used post-knee or hip replacement. Lifestyle changes, such as healthy eating, exercise, weight management, and smoking cessation, further mitigate clot risk. Common side effects include headache, low platelet count, and fever; increased bleeding (nosebleeds, bruising) may occur, necessitating caution with sharp objects. This medication isn't suitable for all; patients with severe liver or kidney disease, those currently bleeding, or on other anticoagulants should inform their physician. Breastfeeding is contraindicated. Unlike some anticoagulants, routine PT-INR monitoring isn't necessary.
Uses of Bivastat 250mg Injection
Preventing and managing blood clot formation.
Major Benefits of Bivastat 250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Bivastat 250mg Injection:
- Low blood platelets
- Headache
- Fever
- Bleeding
How to use Bivastat 250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Bivastat 250mg Injection works:
Bivastat 250mg injectable solution is a medication that inhibits blood clot development, thus reducing the risk of harmful thrombi.
SAFETY ADVICE
AlcoholUNSAFE
Bivastat 250mg Injection should not be used concurrently with alcohol consumption.
PregnancySAFE IF PRESCRIBED
Administering Bivastat 250mg Injection during pregnancy is typically deemed safe. Preclinical trials using animals revealed minimal or no harmful consequences for the fetus; nevertheless, data from human trials are scarce.
Breast feedingCONSULT YOUR DOCTOR
Administration of Bivastat 250mg Injection while breastfeeding is likely inadvisable. Scant evidence from human studies indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingNOT RELEVANT
Inapplicable, given that Bivastat 250mg Injection is administered solely within a hospital setting.
KidneyCAUTION
Exercise caution when administering Bivastat 250mg Injection to individuals with impaired renal function; dosage modification may be necessary. Consult a physician for guidance. Bivastat 250mg Injection is contraindicated in patients exhibiting severe kidney disease or undergoing dialysis.
LiverSAFE IF PRESCRIBED
The use of Bivastat 250mg Injection in patients with liver disease appears to pose minimal risk. Preliminary evidence indicates dose modification may not be necessary. Physician consultation is recommended.
What if you forget to take Bivastat 250mg Injection :
NA
Facts to Know About Bivastat 250mg Injection
| Label | Value |
|---|---|
| Chemical Category | Peptide chains |
| Developing Habits | No. |
| Treatment Category | Heart |
| Actions | Injectable direct thrombin inhibitor |
